Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: J Bone Miner Res. 2015 Mar;30(3):539–549. doi: 10.1002/jbmr.2372

Figure 6. Pharmacokinetic results.

Figure 6

Eight animals had blood drawn for measurement of the anti-sclerostin antibody 6 and 24 hours after the first and fifth dose.. The y-axis represents the measured level of the anti-sclerostin antibody (BPS804) in the blood of each animal. Each symbol represents a different animal. * = the presence of auto-antibodies in serum at that time point. For the animal denoted by the open square (++), levels were undetectable at dose 5 and auto antibodies were present.